Eyeing faster path for sickle cell drug, Peninsula biotech plots expansion — for a higher price

Less than a year after moving into one of South San Francisco’s new biotech real estate developments, Global Blood Therapeutics Inc. will be moving again, nearly tripling its space as it shifts operations just a few yards away.

Like any biotech company looking to move digs in a tight real estate market, Global Blood will pay top dollar to do so.

Even as real estate developers add millions of square feet in South San Francisco alone, it is being snatched up quickly by large pharmaceutical companies…